UniProt ID | DONS_HUMAN | |
---|---|---|
UniProt AC | Q9NYP3 | |
Protein Name | Protein downstream neighbor of Son | |
Gene Name | DONSON | |
Organism | Homo sapiens (Human). | |
Sequence Length | 566 | |
Subcellular Localization | Nucleus . Localizes at DNA replication sites. | |
Protein Description | Replisome component that maintains genome stability by protecting stalled or damaged replication forks. After the induction of replication stress, required for the stabilization of stalled replication forks, the efficient activation of the intra-S-phase and G/2M cell-cycle checkpoints and the maintenance of genome stability.. | |
Protein Sequence | MALSVPGYSPGFRKPPEVVRLRRKRARSRGAAASPPRELTEPAARRAALVAGLPLRPFPAAGGRGGGSGGGPAAARRNPFARLDNRPRVAAEPPDGPAREQPEAPVPFLDSNQENDLLWEEKFPERTTVTELPQTSHVSFSEPDIPSSKSTELPVDWSIKTRLLFTSSQPFTWADHLKAQEEAQGLVQHCRATEVTLPKSIQDPKLSSELRCTFQQSLIYWLHPALSWLPLFPRIGADRKMAGKTSPWSNDATLQHVLMSDWSVSFTSLYNLLKTKLCPYFYVCTYQFTVLFRAAGLAGSDLITALISPTTRGLREAMRNEGIEFSLPLIKESGHKKETASGTSLGYGEEQAISDEDEEESFSWLEEMGVQDKIKKPDILSIKLRKEKHEVQMDHRPESVVLVKGINTFTLLNFLINSKSLVATSGPQAGLPPTLLSPVAFRGATMQMLKARSVNVKTQALSGYRDQFSLEITGPIMPHSLHSLTMLLKSSQSGSFSAVLYPHEPTAVFNICLQMDKVLDMEVVHKELTNCGLHPNTLEQLSQIPLLGKSSLRNVVLRDYIYNWRS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Phosphorylation | ----MALSVPGYSPG ----CCCCCCCCCCC | 19.41 | 22199227 | |
8 | Phosphorylation | MALSVPGYSPGFRKP CCCCCCCCCCCCCCC | 12.96 | 25850435 | |
9 | Phosphorylation | ALSVPGYSPGFRKPP CCCCCCCCCCCCCCH | 25.18 | 29255136 | |
28 | Phosphorylation | LRRKRARSRGAAASP HHHHHHHHCCCCCCC | 33.80 | 23917254 | |
29 | Methylation | RRKRARSRGAAASPP HHHHHHHCCCCCCCC | 32.96 | - | |
34 | Phosphorylation | RSRGAAASPPRELTE HHCCCCCCCCHHHCH | 30.61 | 28191891 | |
40 | Phosphorylation | ASPPRELTEPAARRA CCCCHHHCHHHHHHH | 34.86 | 30108239 | |
56 | Methylation | LVAGLPLRPFPAAGG HHHCCCCCCCCCCCC | 28.95 | - | |
64 | Methylation | PFPAAGGRGGGSGGG CCCCCCCCCCCCCCC | 39.40 | - | |
122 | Ubiquitination | NDLLWEEKFPERTTV CCCCHHHCCCCCCEE | 55.49 | - | |
135 | Phosphorylation | TVTELPQTSHVSFSE EEEECCCCCCCCCCC | 20.89 | 23186163 | |
136 | Phosphorylation | VTELPQTSHVSFSEP EEECCCCCCCCCCCC | 19.35 | 23186163 | |
139 | Phosphorylation | LPQTSHVSFSEPDIP CCCCCCCCCCCCCCC | 20.03 | 25159151 | |
141 | Phosphorylation | QTSHVSFSEPDIPSS CCCCCCCCCCCCCCC | 40.49 | 23186163 | |
149 | Ubiquitination | EPDIPSSKSTELPVD CCCCCCCCCCCCCCC | 66.78 | 29967540 | |
160 (in isoform 1) | Ubiquitination | - | 23.29 | 21906983 | |
160 | Ubiquitination | LPVDWSIKTRLLFTS CCCCEEEEEEEEEEC | 23.29 | 2190698 | |
160 (in isoform 2) | Ubiquitination | - | 23.29 | 21906983 | |
160 (in isoform 3) | Ubiquitination | - | 23.29 | 21906983 | |
193 | Phosphorylation | LVQHCRATEVTLPKS HHHHHHEEECCCCCC | 16.19 | 20860994 | |
199 | Ubiquitination | ATEVTLPKSIQDPKL EEECCCCCCCCCCCC | 64.40 | 29967540 | |
200 | Phosphorylation | TEVTLPKSIQDPKLS EECCCCCCCCCCCCC | 24.44 | 20860994 | |
208 | Phosphorylation | IQDPKLSSELRCTFQ CCCCCCCHHHCHHHH | 51.60 | 24719451 | |
275 | Phosphorylation | SLYNLLKTKLCPYFY HHHHHHHHCCCCCEE | 29.26 | 24905233 | |
280 | Phosphorylation | LKTKLCPYFYVCTYQ HHHCCCCCEEEEHHH | 13.42 | 24905233 | |
282 | Phosphorylation | TKLCPYFYVCTYQFT HCCCCCEEEEHHHHH | 6.70 | 24905233 | |
285 | Phosphorylation | CPYFYVCTYQFTVLF CCCEEEEHHHHHHHH | 15.43 | 24905233 | |
286 | Phosphorylation | PYFYVCTYQFTVLFR CCEEEEHHHHHHHHH | 9.12 | 24905233 | |
289 | Phosphorylation | YVCTYQFTVLFRAAG EEEHHHHHHHHHHHC | 10.77 | 24905233 | |
326 | Phosphorylation | RNEGIEFSLPLIKES HHCCCCEEEEEHHHC | 19.11 | - | |
333 | Phosphorylation | SLPLIKESGHKKETA EEEEHHHCCCCEECC | 40.99 | 28555341 | |
354 | Phosphorylation | YGEEQAISDEDEEES CCCCCCCCCCCHHHH | 37.65 | 28348404 | |
361 | Phosphorylation | SDEDEEESFSWLEEM CCCCHHHHHHHHHHC | 28.06 | 28348404 | |
363 | Phosphorylation | EDEEESFSWLEEMGV CCHHHHHHHHHHCCC | 39.78 | 28348404 | |
381 | Phosphorylation | IKKPDILSIKLRKEK CCCCCEEEEEECCCC | 20.29 | 24719451 | |
420 | Phosphorylation | NFLINSKSLVATSGP HHHHCCCCCCCCCCC | 28.09 | 22817900 | |
445 | Phosphorylation | PVAFRGATMQMLKAR CCHHCCHHHHHHHHC | 15.68 | 26074081 | |
453 | Phosphorylation | MQMLKARSVNVKTQA HHHHHHCCCCCCHHH | 23.93 | 26074081 | |
457 | Ubiquitination | KARSVNVKTQALSGY HHCCCCCCHHHHCCC | 29.71 | - | |
458 | Phosphorylation | ARSVNVKTQALSGYR HCCCCCCHHHHCCCC | 18.13 | 26074081 | |
462 | Phosphorylation | NVKTQALSGYRDQFS CCCHHHHCCCCCCEE | 36.47 | 26074081 | |
464 | Phosphorylation | KTQALSGYRDQFSLE CHHHHCCCCCCEEEE | 13.98 | 26074081 | |
537 | Phosphorylation | NCGLHPNTLEQLSQI HCCCCCCHHHHHHCC | 35.80 | 25627689 | |
542 | Phosphorylation | PNTLEQLSQIPLLGK CCHHHHHHCCCCCCC | 26.26 | 25627689 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of DONS_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DONS_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DONS_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of DONS_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-420, AND MASSSPECTROMETRY. |